Solventum Corporation (BST:KB7)
72.60
-1.00 (-1.36%)
At close: Dec 3, 2025
Solventum Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 8,402 | 8,254 | 8,197 | 8,130 | 8,171 | 7,281 |
| Revenue Growth (YoY) | 2.28% | 0.69% | 0.82% | -0.50% | 12.22% | - |
| Cost of Revenue | 3,831 | 3,642 | 3,504 | 3,435 | 3,248 | 2,966 |
| Gross Profit | 4,571 | 4,612 | 4,693 | 4,695 | 4,923 | 4,315 |
| Selling, General & Admin | 3,083 | 2,752 | 2,247 | 2,236 | 2,282 | 2,169 |
| Research & Development | 751 | 768 | 758 | 767 | 766 | 719 |
| Operating Expenses | 3,834 | 3,520 | 3,005 | 3,003 | 3,048 | 2,888 |
| Operating Income | 737 | 1,092 | 1,688 | 1,692 | 1,875 | 1,427 |
| Interest Expense | -403 | -367 | - | - | - | - |
| Other Non Operating Income (Expenses) | -11 | -57 | -21 | - | 7 | 1 |
| EBT Excluding Unusual Items | 323 | 668 | 1,667 | 1,692 | 1,882 | 1,428 |
| Merger & Restructuring Charges | -90 | -62 | - | - | - | - |
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 12 |
| Pretax Income | 1,669 | 606 | 1,667 | 1,692 | 1,882 | 1,440 |
| Income Tax Expense | 145 | 127 | 321 | 349 | 422 | 302 |
| Net Income | 1,524 | 479 | 1,346 | 1,343 | 1,460 | 1,138 |
| Net Income to Common | 1,524 | 479 | 1,346 | 1,343 | 1,460 | 1,138 |
| Net Income Growth | 111.67% | -64.41% | 0.22% | -8.01% | 28.29% | - |
| Shares Outstanding (Basic) | 174 | 173 | 173 | 173 | - | - |
| Shares Outstanding (Diluted) | 175 | 174 | 173 | 173 | - | - |
| Shares Change (YoY) | 1.01% | 0.58% | - | - | - | - |
| EPS (Basic) | 8.76 | 2.77 | 7.79 | 7.78 | - | - |
| EPS (Diluted) | 8.72 | 2.76 | 7.79 | 7.78 | - | - |
| EPS Growth | 110.21% | -64.57% | 0.17% | - | - | - |
| Free Cash Flow | 50 | 805 | 1,625 | 1,428 | 1,925 | 1,755 |
| Free Cash Flow Per Share | 0.29 | 4.63 | 9.41 | 8.27 | - | - |
| Gross Margin | 54.40% | 55.88% | 57.25% | 57.75% | 60.25% | 59.26% |
| Operating Margin | 8.77% | 13.23% | 20.59% | 20.81% | 22.95% | 19.60% |
| Profit Margin | 18.14% | 5.80% | 16.42% | 16.52% | 17.87% | 15.63% |
| Free Cash Flow Margin | 0.60% | 9.75% | 19.82% | 17.57% | 23.56% | 24.10% |
| EBITDA | 1,259 | 1,647 | 2,249 | 2,270 | 2,472 | 2,026 |
| EBITDA Margin | 14.99% | 19.95% | 27.44% | 27.92% | 30.25% | 27.83% |
| D&A For EBITDA | 522 | 555 | 561 | 578 | 597 | 599 |
| EBIT | 737 | 1,092 | 1,688 | 1,692 | 1,875 | 1,427 |
| EBIT Margin | 8.77% | 13.23% | 20.59% | 20.81% | 22.95% | 19.60% |
| Effective Tax Rate | 8.69% | 20.96% | 19.26% | 20.63% | 22.42% | 20.97% |
| Revenue as Reported | 8,402 | 8,254 | 8,197 | 8,130 | 8,171 | 7,281 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.